Thursday, April 08, 2010 10:36:54 PM
FDA VVUS July 13 & Oct 28, 2010
Vivus (VVUS)
Drug/indication: Qnexa for obesity
Approval decision date: October 28
The FDA has scheduled an advisory committee meeting on July 15 to review Qnexa's safety and efficacy as a weight-loss drug. The FDA's review of Qnexa will be posted to the agency's web site on July 13 or July 14.
Vivus (VVUS)
Drug/indication: Qnexa for obesity
Approval decision date: October 28
The FDA has scheduled an advisory committee meeting on July 15 to review Qnexa's safety and efficacy as a weight-loss drug. The FDA's review of Qnexa will be posted to the agency's web site on July 13 or July 14.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
